查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1873164

全球生物外科市場

Biosurgery
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球生物外科市場預計2030年將達到184億美元。

全球生物外科市場規模在2024年估計為145億美元，預計到2030年將達到184億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為4.1%。本報告分析的細分市場之一—骨移植替代材料，預計將以3.9%的複合年成長率成長，並在分析期結束時達到72億美元。止血劑細分市場預計在分析期間將以3.6%的複合年成長率成長。

美國市場規模估計為39億美元，而中國市場預計將以3.9%的複合年成長率成長。

據估計，2024年美國生物醫學外科市場規模將達39億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到29億美元，在2024年至2030年的分析期間內，年複合成長率（CAGR）為3.9%。其他值得關注的區域市場包括日本和加拿大，預計在分析期內，這兩個市場的年複合成長率將分別達到3.7%和3.4%。在歐洲，德國的年複合成長率預計將達到約3.1%。

全球生物醫學外科手術市場—主要趨勢與促進因素概述

什麼是果凍？為什麼它在現代醫學中越來越受到重視？

果凍是醫療科技領域一個創新且快速發展的分支，但它究竟包含哪些內容呢？廣義而言，果凍是指利用生物來源或生物相容性材料輔助外科手術。這些材料旨在與人體無縫結合，促進癒合，最大限度地減少併發症，並經常為傳統外科技術提供替代方案。生物外科的應用範圍十分廣泛，涵蓋止血（阻止出血的過程）、組織再生，甚至包括使用可與活體組織整合的生物活性植入。人們對微創手術日益成長的興趣，以及對更快康復時間和更短住院時間的需求，顯著提升了對生物外科技術的興趣。隨著全球醫療保健系統越來越重視患者療效和成本效益，生物外科已穩固確立其作為現代外科護理基礎技術的地位。

最尖端科技如何形塑生物外科的未來？

生物外科領域正因技術進步而發生翻天覆地的變化，但具體有哪些變化正在發生？其中一個最重要的進展是再生醫學領域，它利用支架和生長因子等生物外科產品來促進受損組織的修復和替換。此外，奈米技術的應用使得更精密的生物材料的研發成為可能，這些材料能夠將藥物和其他治療劑直接輸送到手術部位，從而促進人體自身的癒合過程。機器人技術和影像技術也發揮關鍵作用，為外科醫生在手術過程中提供了前所未有的精準度和控制力。此外，3D列印技術的出現使得客製化植入物和移植物成為可能，植入和移植物可根據患者的個別情況量身定做，從而降低排異反應的風險並改善治療效果。隨著這些技術的不斷發展，生物外科的潛在應用範圍將不斷擴大，並有望徹底改變外科手術的進行方式。

為什麼果凍正成為複雜外科手術的首選？

生物外科產品的獨特功能正推動其在複雜且具挑戰性的外科手術中廣泛應用，但究竟是什麼使其如此重要？在許多情況下，傳統外科技術創傷過大或無法達到預期效果，尤其是涉及大面積組織損傷或精細結構的病例。生物外科產品，例如纖維蛋白膠、膠原蛋白基質和合成移植物，為外科醫生提供了增強人體自然癒合過程、降低併發症風險並提高整體手術成功率的工具。例如，在心血管外科手術中，生物外科在血管修復和預防過度出血方面發揮著至關重要的作用。在整形外科手術中，生物活性材料正被用於促進骨再生和提高植入的完整性。此外，生物外科在創傷護理領域的應用也不斷擴展，尤其是對傳統治療方法無效的慢性傷口。隨著醫療產業不斷面臨人口老化和慢性病日益增多的挑戰，生物外科在應對這些疾病方面的作用預計將變得更加重要。

推動生物外科市場快速擴張的因素有哪些？

果凍市場的成長受多種因素驅動，這些因素共同推動了對這些先進外科解決方案的需求不斷成長。技術創新，特別是生物材料和再生醫學領域的創新，顯著拓展了果凍的應用範圍，使其成為各個醫學領域更具可行性的選擇。此外，糖尿病和心血管疾病等慢性病的日益普遍，導致傳統方法難以應對的複雜手術病例不斷增加。消費者行為也在影響這一趨勢，患者越來越傾向於選擇微創手術，以縮短恢復時間並減少副作用。醫療服務提供者對生物外科的認知和接受度不斷提高，也進一步推動了其應用，因為越來越多的臨床醫生認知到這些技術在改善患者預後方面的益處。此外，全球人口老化也促進了對生物外科產品的需求，因為老年患者更有可能需要受益於這些先進技術的外科手術。最後，政府的支持性政策和對醫療保健基礎設施（尤其是在新興市場）不斷增加的投資，為生物外科市場的發展創造了有利環境，確保了這個充滿活力的領域的持續成長和創新。

部分：

依產品（骨移植替代品、止血劑、軟組織固定劑、外科密封劑、沾黏抑制劑）、依應用（一般外科、整形外科、整形外科、婦科手術、其他應用）、依最終用途（醫院、診所、其他最終用途）分類

受訪公司範例

  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • Hemostasis, LLC
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • MAQUET Holding BV & Co. KG
  • Medtronic PLC
  • Pfizer, Inc.
  • Sanofi US
  • Stryker Corporation

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，改變您分析市場和競爭情報的方式。

Global Industry Analysts 並沒有依賴通用的 LLM 或查詢產業專用的SLM，而是建立了一個由世界各地領域專家精心整理的內容庫，包括視訊轉錄、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在我們的最新報告中，全球產業分析師將關稅對地域市場的影響納入考量，並根據公司總部所在國、製造地以及進出口（成品和OEM產品）情況，預測企業競爭地位的變化。這種複雜多變的市場現實將透過微觀和宏觀市場動態影響競爭對手，包括銷貨成本增加、盈利下降以及供應鏈重組。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 世界其他地區

第4章 競賽

簡介目錄
Product Code: MCP10738

Global Biosurgery Market to Reach US$18.4 Billion by 2030

The global market for Biosurgery estimated at US$14.5 Billion in the year 2024, is expected to reach US$18.4 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Bone Graft Substitutes, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$7.2 Billion by the end of the analysis period. Growth in the Hemostatic Agents segment is estimated at 3.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.9 Billion While China is Forecast to Grow at 3.9% CAGR

The Biosurgery market in the U.S. is estimated at US$3.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 3.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Biosurgery Market - Key Trends and Drivers Summarized

What Is Biosurgery, and Why Is It Gaining Traction in Modern Medicine?

Biosurgery is an innovative and rapidly evolving field within medical technology, but what exactly does it encompass? Broadly speaking, biosurgery involves the use of biologically-based or biocompatible materials to aid in surgical procedures. These materials are engineered to interact seamlessly with the human body, promoting healing, minimizing complications, and often providing alternatives to traditional surgical methods. The scope of biosurgery is extensive, covering areas such as hemostasis (the process of stopping bleeding), tissue regeneration, and even the use of bioactive implants that can integrate with living tissues. The growing emphasis on less invasive procedures, combined with the desire for faster recovery times and reduced hospital stays, has significantly increased interest in biosurgical techniques. As healthcare systems across the globe prioritize patient outcomes and cost-effectiveness, biosurgery is poised to become a cornerstone of modern surgical practice.

How Are Cutting-Edge Technologies Shaping the Future of Biosurgery?

The landscape of biosurgery is being dramatically transformed by advancements in technology, but how exactly are these changes unfolding? One of the most significant developments has been in the field of regenerative medicine, where biosurgical products such as scaffolds and growth factors are used to facilitate the repair or replacement of damaged tissues. Additionally, the integration of nanotechnology is allowing for the creation of more sophisticated biomaterials that can deliver drugs or other therapeutic agents directly to the site of surgery, enhancing the body's natural healing processes. Robotics and imaging technologies are also playing a crucial role, providing surgeons with unprecedented precision and control during procedures. Furthermore, the advent of 3D printing is opening up new possibilities for custom implants and grafts that are tailored to individual patients, reducing the risk of rejection and improving outcomes. As these technologies continue to evolve, the potential applications of biosurgery are expanding, promising to revolutionize the way surgeries are performed.

Why Is Biosurgery Becoming the Go-To Option for Complex Surgical Cases?

The unique capabilities of biosurgical products are driving their adoption in complex and challenging surgical cases, but what makes them so indispensable? In many instances, traditional surgical methods are either too invasive or unable to achieve the desired outcomes, particularly in cases involving extensive tissue damage or delicate structures. Biosurgical products, such as fibrin sealants, collagen-based matrices, and synthetic grafts, provide surgeons with tools that can enhance the body's natural ability to heal, reduce the risk of complications, and improve the overall success rate of surgeries. For example, in cardiovascular surgery, biosurgery is playing a pivotal role in the repair of blood vessels and the prevention of excessive bleeding. In orthopedic surgery, bioactive materials are being used to promote bone regeneration and improve the integration of implants. Moreover, biosurgery is finding increasing applications in wound care, particularly in chronic wounds that are resistant to conventional treatments. As the healthcare industry continues to grapple with the challenges of an aging population and the rising prevalence of chronic diseases, the role of biosurgery in managing these conditions is set to grow.

What Is Fueling the Rapid Expansion of the Biosurgery Market?

The growth in the biosurgery market is driven by several factors, each contributing to the increasing demand for these advanced surgical solutions. Technological innovations, particularly in biomaterials and regenerative medicine, have significantly expanded the range of applications for biosurgery, making it a more viable option across various medical disciplines. Additionally, the rising prevalence of chronic diseases, such as diabetes and cardiovascular conditions, is leading to an increase in complex surgical cases where traditional methods may fall short. Consumer behavior is also playing a role, with patients increasingly seeking out minimally invasive procedures that offer quicker recovery times and fewer side effects. The growing awareness and acceptance of biosurgery among healthcare providers further drive its adoption, as more clinicians recognize the benefits of these techniques in improving patient outcomes. Moreover, the aging global population is contributing to the demand for biosurgical products, as older patients are more likely to require surgical interventions that benefit from these advanced technologies. Finally, supportive government policies and increased investment in healthcare infrastructure, particularly in emerging markets, are providing the necessary environment for the biosurgery market to thrive, ensuring continued growth and innovation in this exciting field.

SCOPE OF STUDY:

The report analyzes the Biosurgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents, Anti-Adhesion Agents); Application (General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery, Other Applications); End-Use (Hospitals, Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 12 Featured) -

  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • Hemostasis, LLC
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • MAQUET Holding B.V. & Co. KG
  • Medtronic PLC
  • Pfizer, Inc.
  • Sanofi U.S.
  • Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Biosurgery - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Minimally Invasive Surgeries Spurs Growth in Biosurgery Market
    • Advancements in Biomaterials and Tissue Engineering Expand Addressable Market Opportunity
    • Increased Use of Biosurgery in Cardiovascular and Orthopedic Procedures Drives Market Adoption
    • Here's How Technological Innovations in Hemostasis and Sealants Propel Market Growth
    • Growing Geriatric Population and Associated Chronic Conditions Generate Demand for Biosurgical Products
    • Emerging Applications of Biosurgery in Regenerative Medicine Sustain Long-Term Market Expansion
    • Shifts Towards Personalized Medicine and Customized Surgical Solutions Throw the Spotlight on Biosurgery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Biosurgery Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Biosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Bone Graft Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Bone Graft Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hemostatic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Hemostatic Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Soft Tissue Attachments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Soft Tissue Attachments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Soft Tissue Attachments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Surgical Sealing Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Surgical Sealing Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Anti-Adhesion Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Anti-Adhesion Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for General Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for General Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Orthopedic Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Orthopedic Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Reconstructive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Reconstructive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Reconstructive Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Gynecological Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Gynecological Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Gynecological Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Biosurgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Biosurgery by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Biosurgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Biosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Biosurgery by Product - Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Biosurgery by Product - Percentage Breakdown of Value Sales for Bone Graft Substitutes, Hemostatic Agents, Soft Tissue Attachments, Surgical Sealing Agents and Anti-Adhesion Agents for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Biosurgery by Application - General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of World 15-Year Perspective for Biosurgery by Application - Percentage Breakdown of Value Sales for General Surgery, Orthopedic Surgery, Reconstructive Surgery, Gynecological Surgery and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Biosurgery by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of World 15-Year Perspective for Biosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION